戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 ssociated genes, commonly occurs among aging human hematopoietic stem cells.
2 ted virus vector, followed by engraftment of human hematopoietic stem cells.
3 ortant cytokine for in vitro manipulation of human hematopoietic stem cells.
4 ping active and repressive marks in purified human hematopoietic stem cells.
5 of nonpermissive mice following injection of human hematopoietic stem cells.
6 em cell factor transgene were engrafted with human hematopoietic stem cells.
7 that this system can support self-renewal of human hematopoietic stem cells.
8  of CD34 can be reversible on reconstituting human hematopoietic stem cells.
9 eld of megakaryocytes in cultures of primary human hematopoietic stem cells.
10  molecular regulation of HOXB4 expression in human hematopoietic stem cells.
11 ems to study the biology and transduction of human hematopoietic stem cells.
12 utically useful levels of gene transfer into human hematopoietic stem cells.
13 ere highly efficient in transducing purified human hematopoietic stem cells.
14 at these conditions may support expansion of human hematopoietic stem cells.
15 y the relatively inefficient transduction of human hematopoietic stem cells.
16 that, in addition to being a marker of adult human hematopoietic stem cells, ACE identifies embryonic
17 34 molecule, expressed almost exclusively on human hematopoietic stem cells and committed progenitors
18                Humanized mice engrafted with human hematopoietic stem cells and developing functional
19 ing with an evaluation of candidate genes in human hematopoietic stem cells and in zebrafish revealed
20 d as a common marker expressed on murine and human hematopoietic stem cells and on cells of the hemat
21 lobal gene expression profiles for mouse and human hematopoietic stem cells and other stages of the h
22 f cytokines for use in in vitro expansion of human hematopoietic stem cells and progenitors.
23 6 fresh myeloid leukemia samples, and normal human hematopoietic stem cells and their mature progeny.
24 a prioritized candidate gene with the use of human hematopoietic stem cells and zebrafish embryos.
25 human immune system following engraftment of human hematopoietic stem cells, and 4) the ability of th
26 with observations in mice, and indicate that human hematopoietic stem cells are enriched in the Kit(l
27                                              Human hematopoietic stem cells are pluripotent, ie, capa
28 upport the concept that telomerase levels in human hematopoietic stem cells are tightly controlled as
29  assay, the best in vitro surrogate test for human hematopoietic stem cells, as well as of the output
30         The efficiency of gene transfer into human hematopoietic stem cells by oncoretroviral vectors
31 leukemia (CML) is a malignant disease of the human hematopoietic stem cell caused by the BCR/ABL gene
32 caveats and utility of this model to analyze human hematopoietic stem cell control in vivo.
33  and flow cytometric analyses confirmed that human hematopoietic stem cells cultured in the presence
34                                     Purified human hematopoietic stem cells develop into mature T lym
35 ults contribute to a better understanding of human hematopoietic stem cell differentiation and provid
36 g2(-/-) gamma(C)(-/-) mice transplanted with human hematopoietic stem cells (DKO-hu-HSC mice) mimic a
37 el of human-pig chimerism, we show that some human hematopoietic stem cells engrafted in pigs contain
38    We examined Borrelia hermsii infection in human hematopoietic stem cell-engrafted nonobese diabeti
39 e variants of a novel cytokine receptor from human hematopoietic stem cells expressing the CD34 antig
40 4(+) or highly purified CD34(+)CD38(-)CD7(-) human hematopoietic stem cells from umbilical cord blood
41 bined immunodeficient (NOD/SCID) mice accept human hematopoietic stem cell grafts, providing a unique
42                                   In CD34(+) human hematopoietic stem cells (hHSC) and K526 cells, th
43 an T cells in vivo from genetically modified human hematopoietic stem cells (hHSC) using a human/mous
44 mouse models, the hu-HSC model is created by human hematopoietic stem cell (HSC) engraftment whereas
45                                  Age-related human hematopoietic stem cell (HSC) exhaustion and myelo
46 actors (GFs) that together promote quiescent human hematopoietic stem cell (HSC) expansion ex vivo ha
47 actors (GFs) that together promote quiescent human hematopoietic stem cell (HSC) expansion ex vivo ha
48 ietic stem and progenitor cells (HSPCs), the human hematopoietic stem cell (HSC) hierarchy contains a
49 methyluracil) to monitor models of mouse and human hematopoietic stem cell (HSC) transplantation.
50           Cotransplantation of human CD34(+) human hematopoietic stem cells (HSC) and hepatocyte prog
51 ficient retroviral-mediated gene transfer to human hematopoietic stem cells (HSC) and insufficient ge
52 expression profile of highly enriched normal human hematopoietic stem cells (HSC) and leukemic stem c
53 ropic retrovirus-mediated gene transfer into human hematopoietic stem cells (HSC) has been a major im
54                     Ex vivo amplification of human hematopoietic stem cells (HSC) without loss of the
55 er for the isolation and characterization of human hematopoietic stem cells (HSCs) and cancer stem ce
56 34 antigen is expressed on most, if not all, human hematopoietic stem cells (HSCs) and hematopoietic
57   Finally, based on nucleosome data from the human hematopoietic stem cells (HSCs) and mouse embryoni
58                Efforts to change the fate of human hematopoietic stem cells (HSCs) and progenitor cel
59                                              Human hematopoietic stem cells (HSCs) are commonly purif
60                                              Human hematopoietic stem cells (HSCs) are generally rega
61                                              Human hematopoietic stem cells (HSCs) exposed to cytokin
62                                   Generating human hematopoietic stem cells (HSCs) from autologous ti
63  date, reconstitution of murine strains with human hematopoietic stem cells (HSCs) from patients with
64                        De novo generation of human hematopoietic stem cells (HSCs) from renewable cel
65           However, the effects of hypoxia on human hematopoietic stem cells (HSCs) have not been char
66                 Efficient gene transfer into human hematopoietic stem cells (HSCs) is an important go
67             Gene transduction of pluripotent human hematopoietic stem cells (HSCs) is necessary for s
68                    Expression of AML1-ETO in human hematopoietic stem cells (HSCs) preferentially enh
69 ncies using mice reconstituted with modified human hematopoietic stem cells (HSCs) remains unclear.
70 further humanized through the engraftment of human hematopoietic stem cells (HSCs) that can lead to h
71 ting potential (MRP) of different sources of human hematopoietic stem cells (HSCs) was directly compa
72            The low levels of transduction of human hematopoietic stem cells (HSCs) with Moloney murin
73 ered by the low frequency of transduction of human hematopoietic stem cells (HSCs) with retroviral ve
74  factor (G-CSF) to promote granulopoiesis of human hematopoietic stem cells (HSCs), neutropenia remai
75 ophage-mediated phagocytosis of transplanted human hematopoietic stem cells (HSCs).
76 antability using limited numbers of purified human hematopoietic stem cells (HSCs).
77  mice as an in vivo assay for transplantable human hematopoietic stem cells (HSCs).
78 , and macrophages after transplantation with human hematopoietic stem cells (hu-HSC) and develops in
79 OD)-scid IL2rgamma(null) mice engrafted with human hematopoietic stem cells (hu-SRC-SCID mice) to cau
80 D/SCID/IL2Rgamma(-/-) mice transplanted with human hematopoietic stem cells [humanized bone marrow li
81                               Engraftment of human hematopoietic stem cells in newborn NRG-Akita and
82                               Engraftment of human hematopoietic stem cells into immunodeficient mice
83                   Transplantation of CD34(+) human hematopoietic stem cells into NSG-SGM3 mice led to
84                           Transplantation of human hematopoietic stem cells into severely immunocompr
85 ntly identified cell-surface marker of adult human hematopoietic stem cells, is already expressed in
86 fort to discover specific markers to isolate human hematopoietic stem cells, Jokubaitis and colleague
87  large transgene cassette can be achieved in human hematopoietic stem cell lines.
88 and Milyavsky et al. now show that mouse and human hematopoietic stem cells make opposing decisions a
89 bone marrow transplantation into rodents and humans, hematopoietic stem cells migrate into the liver
90 ese observations indicate that fractionating human hematopoietic stem cells on the basis of ALDH acti
91 ewal, differentiation, and transformation of human hematopoietic stem cells or to evaluate the effica
92 neage developmental potential of a candidate human hematopoietic stem cell population, CD34+CD38- cel
93 )/(-) mice humanized with cord blood-derived human hematopoietic stem cells produce human T cells tha
94  model of DF in which mice transplanted with human hematopoietic stem cells produced signs of DENV di
95 he transplantation of defined populations of human hematopoietic stem cells resulted in the establish
96                                   Murine and human hematopoietic stem cells share a number of express
97 ssed in proliferating adult cells, including human hematopoietic stem cells, T-lymphocytes, and eryth
98  been able to engraft murine recipients with human hematopoietic stem cells that develop into functio
99 , the feasibility of 2bF8LV gene delivery to human hematopoietic stem cells to introduce FVIII expres
100          Retroviral-mediated transduction of human hematopoietic stem cells to provide a lifelong sup
101 rapy of blood disorders is the resistance of human hematopoietic stem cells to stable genetic modific
102 use it has proven predictive for outcomes in human hematopoietic stem cell transplantation.
103 feration and engraftment potential of normal human hematopoietic stem cells via the engagement of pur
104                              Flu toxicity to human hematopoietic stem cells was evaluated by CD34+ ce
105                                        Using human hematopoietic stem cells, we show that inhibition

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。
 
Page Top